| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/23/2001 | EP1100829A2 Use of cd25 binding molecules in the treatment of rheumatoid arthritis or skin diseases |
| 05/23/2001 | EP1100827A2 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 05/23/2001 | EP1100826A1 Isoforms of human calcium sensing receptor |
| 05/23/2001 | EP1100824A1 Compounds with growth hormone releasing properties |
| 05/23/2001 | EP1100823A2 Novel peptides for use in immunotherapy of autoimmune diseases |
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100821A2 Anti-inflammatory compounds |
| 05/23/2001 | EP1100820A1 Pectic substance as a growth factor stabilizer |
| 05/23/2001 | EP1100819A2 Antagonists specific for the corticotropin-releasing factor receptor type 2 (crfr2) |
| 05/23/2001 | EP1100818A1 Inhibitors of hiv membrane fusion |
| 05/23/2001 | EP1100816A1 Aerothricin analogs, their preparation and use |
| 05/23/2001 | EP1100815A1 Protease susceptibility ii |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100813A1 HUMAN BOMBESIN RECEPTOR SUBTYPE-3sb |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100782A1 Amino-aldehyde solid support, linker therefor and methods of preparation and use thereof |
| 05/23/2001 | EP1100771A1 Compounds and compositions for delivering active agents |
| 05/23/2001 | EP1100589A2 Use of l-carnitine and its alkanoyl derivatives in the preparation of medicaments with anticancer activity |
| 05/23/2001 | EP1100547A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 05/23/2001 | EP1100546A1 Dna cytokine vaccines and use of same for protective immunity against multiple sclerosis |
| 05/23/2001 | EP1100545A1 Regulated expression of recombinant proteins using rna viruses |
| 05/23/2001 | EP1100543A2 Conjugates targeted to the interleukin-2 receptors |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100541A1 Hydrogel for the therapeutic treatment of aneurysms |
| 05/23/2001 | EP1100535A1 Targeting pharmaceutical agents to injured tissues |
| 05/23/2001 | EP1100534A1 Equine system for non-surgical artificial insemination |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100532A2 Methods of using lanreotide, a somatostatin analogue |
| 05/23/2001 | EP1100531A1 Method of treating polycystic ovarian syndrome using igf/igfbp-3 |
| 05/23/2001 | EP1100530A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 05/23/2001 | EP1100529A1 Thymosin beta 4 promotes wound repair |
| 05/23/2001 | EP1100528A2 Use of novel agents inducing cell death in synergy with interferons |
| 05/23/2001 | EP1100527A2 Receptor ligand antagonist complexes and their use in treating or preventing receptor mediated diseases |
| 05/23/2001 | EP1100526A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100523A1 Treatment of central nervous system ischemia or trauma with epidermal growth factor-like polypeptides |
| 05/23/2001 | EP1100522A1 Pulmonary delivery of active agents |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100504A2 Pharmaceutical compositions and their uses for treatment of demyelinating disorders |
| 05/23/2001 | EP1100463A1 New injectable formulations containing ramoplanin |
| 05/23/2001 | EP1100462A2 Methods of ophthalmic administration |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP0789709B1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 05/23/2001 | EP0689600B1 Process to induce the death of tumor cells |
| 05/23/2001 | EP0215907B1 Parasite-derived resistance |
| 05/23/2001 | DE19956029A1 Active substance carrier system based on coating a substance with enzymatically cleavable side groups, useful for gene therapy especially of cancer and inflammation |
| 05/23/2001 | CN1296529A Method for screening therapeutic agents |
| 05/23/2001 | CN1296495A TPAACE06: human PTD 016 |
| 05/23/2001 | CN1296494A New compound |
| 05/23/2001 | CN1296414A IL-12 enhancement of immune responses to T-isdependent antigens |
| 05/23/2001 | CN1296413A Composition and method for modulating cytokine release in response to genotoxic agents |
| 05/23/2001 | CN1296014A Novel human growth arrestin and coding sequence thereof |
| 05/23/2001 | CN1296013A Novel human membrane granulosa protein and coding sequence |
| 05/23/2001 | CN1295862A Medicine for treating osteoporosis and hyperosteogeny and preparation process thereof |
| 05/23/2001 | CN1295846A Earthworm compound capsule |
| 05/23/2001 | CN1066246C Axial flow valve system for linear compressor |
| 05/23/2001 | CN1066065C Interferon solution |
| 05/22/2001 | US6235969 Cloning pigs using donor nuclei from non-quiescent differentiated cells |
| 05/22/2001 | US6235929 Tripeptide α-ketoamides |
| 05/22/2001 | US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 05/22/2001 | US6235891 Glucocorticoid receptor agonist and decreased PP5 |
| 05/22/2001 | US6235885 Central nervous system disorders |
| 05/22/2001 | US6235883 Human monoclonal antibodies to epidermal growth factor receptor |
| 05/22/2001 | US6235881 Polypeptides encoded by novel HIV-2 proviruses |
| 05/22/2001 | US6235880 Polypeptides; hypoglycemic agent |
| 05/22/2001 | US6235879 Apoptosis modulators that interact with the Huntington's disease gene |
| 05/22/2001 | US6235878 Apoptosis induction |
| 05/22/2001 | US6235877 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 05/22/2001 | US6235872 Genetic engineering |
| 05/22/2001 | US6235771 Anilide derivative, production and use thereof |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235755 FSH mimetics for the treatment of infertility |
| 05/22/2001 | US6235723 Antisense oligonucleotide modulation of human protein kinase C-δ expression |
| 05/22/2001 | US6235721 Oxidation resistance |
| 05/22/2001 | US6235719 Controlling sleep cycle |
| 05/22/2001 | US6235718 Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm |
| 05/22/2001 | US6235717 Pharmaceutical compounds |
| 05/22/2001 | US6235716 Multivalent ligands which modulate angiogenesis |
| 05/22/2001 | US6235714 Methods for identifying inducers and inhibitors of proteolytic antibodies, compositions and their uses |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235712 Non-aqueous polar aprotic peptide formulations |
| 05/22/2001 | US6235711 Cell adhesion ihibiting compounds |
| 05/22/2001 | US6235710 Spray dried erythropoietin |
| 05/22/2001 | US6235709 Inhibitor of helicobacter pylori colonization |
| 05/22/2001 | US6235708 Testis-specific cystatin-like protein cystatin T |
| 05/22/2001 | US6235707 Anticoagulant peptidyl-arginine aldehyde derivatives |
| 05/22/2001 | US6235525 Nucleotide sequence; diagnosis; vaccines; transfected cell line |
| 05/22/2001 | US6235523 Vector having nucleic acid encoding a human papillomavirus-16 e7 antigen lacking the rb protein binding site and operably linked to a cytomegalo virus promoter; vaccines |
| 05/22/2001 | US6235513 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235512 Nucleic acid encoding polypeptide of defined amino acid sequence which regulates transcription factor, nuclear factor kappa b, activation; hybridization probes and primers; antibodies; diagnosis; therapy |
| 05/22/2001 | US6235500 Oxygen-binding heme proteins incorporating circularly-permuted globins |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235492 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235477 Purified polypeptide |
| 05/22/2001 | US6235304 Method of inhibition of HIV replication by leukemia inhibitory factor |
| 05/22/2001 | US6235291 Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
| 05/22/2001 | US6235289 Intraspinal methods for treating pain |
| 05/22/2001 | US6235286 Adult-onset diabetes treatment method |